BALDI, ELISABETTA
BALDI, ELISABETTA
Medicina Sperimentale e Clinica
[Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications]
1987 M. Mannelli; C. Pupilli; E. Baldi; M. L. DeFeo
A novel cross-species inhibitor to study the function of CatSper Ca(2+) channels in sperm.
2018 Rennhack A, Schiffer C, Brenker C, Fridman D, Nitao ET, Cheng YM, Tamburrino L, Balbach M, Stölting G, Berger TK, Kierzek M, Alvarez L, Wachten D, Zeng XH4, Baldi E, Publicover SJ, Benjamin Kaupp U, Strünker T.
A novel functional estrogen receptor on human sperm membrane interferes with progesterone effects.
2000 E. BALDI; M. LUCONI; M. MURATORI; G. FORTI
Acrosome reaction is impaired in spermatozoa of obese men: a preliminary study
2014 Samavat J; Natali I; Degl'Innocenti S; Filimberti E; Cantini G; Di Franco A; Danza G; Seghieri G; Lucchese M; Baldi E; Forti G; Luconi M
Actions of progesterone on human sperm: a model of non-genomic effects of steroids.
1995 E. Baldi; C. Krausz; M. Luconi; L. Bonaccorsi; M. Maggi; G. Forti
Acute effects on human sperm exposed in vitro to cadmium chloride and diisoutyl-phthalate
2019 Marchiani S, Tamburrino L, Farnetani G, Muratori M, Vignozzi L, Baldi E.
Adverse effects of in vitro manipulation of spermatozoa
2020 Elisabetta Baldi , Lara Tamburrino, Monica Muratori, Selene Degl'Innocenti, Sara Marchiani
Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines.
2007 L. BONACCORSI ;D. NOSI ; M. MURATORI ; L. FORMIGLI ;G. FORTI ; E. BALDI
Androgen deprivation therapy in prostate cancer: focusing on sexual side effects
2012 G. Corona; M. Gacci; E. Baldi; R. Mancina; G. Forti; M. Maggi
Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens.
2012 Tamburrino L; Salvianti F; Marchiani S; Pinzani P; Nesi G; Serni S; Forti G; Baldi E.
Androgen receptor and prostate cancer invasion.
2003 L. BONACCORSI ; M. MURATORI ; V. CARLONI ;S. ZECCHI-ORLANDINI ; L. FORMIGLI; G. FORTI ; E. BALDI
Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype.
2000 BONACCORSI L; CARLONI V; MURATORI M; SALVADORI A; GIANNINI A; CARINI M; SERIO M; G. FORTI; BALDI E.
Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype.
2000 Bonaccorsi L;Carloni V;Muratori M;Salvadori A;Giannini A;Carini M;Serio M;Forti G;Baldi E
Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
2002 ROSINI P; BONACCORSI L; BALDI E; CHIASSERINI C; G. FORTI; DE CHIARA G; LUCIBELLO M; MONGIAT M; IOZZO RV; GARACI E; COZZOLINO F; TORCIA M
Androgen receptor: good guy or bad guy in prostate cancer invasion?
2003 E. BALDI; L. BONACCORSI; G. FORTI
Androgen regulation of prostate cancer: where are we now?
2011 Corona G; Baldi E; Maggi M.
ANDROGEN-RESPONSIVE AND -UNRESPONSIVE PROSTATE CANCER CELL LINES RESPOND DIFFERENTLY TO STIMULI INDUCING NEUROENDOCRINE DIFFERENTIATION
2010 S. Marchiani; L. Tamburrino; G. Nesi; M. Paglierani; S. Gelmini; C. Orlando;M. Maggi; G. Forti; E. Baldi
Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis
2022 Corona, G; Vena, W; Pizzocaro, A; Pallotti, F; Paoli, D; Rastrelli, G; Baldi, E; Cilloni, N; Gacci, M; Semeraro, F; Salonia, A; Minhas, S; Pivonello, R; Sforza, A; Vignozzi, L; Isidori, A M; Lenzi, A; Maggi, M; Lombardo, F
ANNEXIN V BINDING AND MEROCYANINE STAINING FAIL TO DETECT HUMAN SPERM CAPACITATION.
2004 M. MURATORI; I. PORAZZI; M. LUCONI; S. MARCHIANI; G. FORTI; E. BALDI.
ANTAGONISTS FOR THE HUMAN OXYTOCIN RECEPTOR: AN IN VITRO STUDY.
1994 M.MAGGI; G.FANTONI; E.BALDI; A.CIONI; S.ROSSI; G.B.VANNELLI; P.MELIN; M.AKERLUND; M.SERIO
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications] | 1987 | M. Mannelli; C. Pupilli; E. Baldi; M. L. DeFeo | |
| A novel cross-species inhibitor to study the function of CatSper Ca(2+) channels in sperm. | 2018 | Rennhack A, Schiffer C, Brenker C, Fridman D, Nitao ET, Cheng YM, Tamburrino L, Balbach M, Stölting G, Berger TK, Kierzek M, Alvarez L, Wachten D, Zeng XH4, Baldi E, Publicover SJ, Benjamin Kaupp U, Strünker T. | |
| A novel functional estrogen receptor on human sperm membrane interferes with progesterone effects. | 2000 | E. BALDI; M. LUCONI; M. MURATORI; G. FORTI | |
| Acrosome reaction is impaired in spermatozoa of obese men: a preliminary study | 2014 | Samavat J; Natali I; Degl'Innocenti S; Filimberti E; Cantini G; Di Franco A; Danza G; Seghieri G; Lucchese M; Baldi E; Forti G; Luconi M | |
| Actions of progesterone on human sperm: a model of non-genomic effects of steroids. | 1995 | E. Baldi; C. Krausz; M. Luconi; L. Bonaccorsi; M. Maggi; G. Forti | |
| Acute effects on human sperm exposed in vitro to cadmium chloride and diisoutyl-phthalate | 2019 | Marchiani S, Tamburrino L, Farnetani G, Muratori M, Vignozzi L, Baldi E. | |
| Adverse effects of in vitro manipulation of spermatozoa | 2020 | Elisabetta Baldi , Lara Tamburrino, Monica Muratori, Selene Degl'Innocenti, Sara Marchiani | |
| Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines. | 2007 | L. BONACCORSI ;D. NOSI ; M. MURATORI ; L. FORMIGLI ;G. FORTI ; E. BALDI | |
| Androgen deprivation therapy in prostate cancer: focusing on sexual side effects | 2012 | G. Corona; M. Gacci; E. Baldi; R. Mancina; G. Forti; M. Maggi | |
| Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens. | 2012 | Tamburrino L; Salvianti F; Marchiani S; Pinzani P; Nesi G; Serni S; Forti G; Baldi E. | |
| Androgen receptor and prostate cancer invasion. | 2003 | L. BONACCORSI ; M. MURATORI ; V. CARLONI ;S. ZECCHI-ORLANDINI ; L. FORMIGLI; G. FORTI ; E. BALDI | |
| Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. | 2000 | BONACCORSI L; CARLONI V; MURATORI M; SALVADORI A; GIANNINI A; CARINI M; SERIO M; G. FORTI; BALDI E. | |
| Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. | 2000 | Bonaccorsi L;Carloni V;Muratori M;Salvadori A;Giannini A;Carini M;Serio M;Forti G;Baldi E | |
| Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation. | 2002 | ROSINI P; BONACCORSI L; BALDI E; CHIASSERINI C; G. FORTI; DE CHIARA G; LUCIBELLO M; MONGIAT M; IOZZO RV; GARACI E; COZZOLINO F; TORCIA M | |
| Androgen receptor: good guy or bad guy in prostate cancer invasion? | 2003 | E. BALDI; L. BONACCORSI; G. FORTI | |
| Androgen regulation of prostate cancer: where are we now? | 2011 | Corona G; Baldi E; Maggi M. | |
| ANDROGEN-RESPONSIVE AND -UNRESPONSIVE PROSTATE CANCER CELL LINES RESPOND DIFFERENTLY TO STIMULI INDUCING NEUROENDOCRINE DIFFERENTIATION | 2010 | S. Marchiani; L. Tamburrino; G. Nesi; M. Paglierani; S. Gelmini; C. Orlando;M. Maggi; G. Forti; E. Baldi | |
| Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis | 2022 | Corona, G; Vena, W; Pizzocaro, A; Pallotti, F; Paoli, D; Rastrelli, G; Baldi, E; Cilloni, N; Gacci, M; Semeraro, F; Salonia, A; Minhas, S; Pivonello, R; Sforza, A; Vignozzi, L; Isidori, A M; Lenzi, A; Maggi, M; Lombardo, F | |
| ANNEXIN V BINDING AND MEROCYANINE STAINING FAIL TO DETECT HUMAN SPERM CAPACITATION. | 2004 | M. MURATORI; I. PORAZZI; M. LUCONI; S. MARCHIANI; G. FORTI; E. BALDI. | |
| ANTAGONISTS FOR THE HUMAN OXYTOCIN RECEPTOR: AN IN VITRO STUDY. | 1994 | M.MAGGI; G.FANTONI; E.BALDI; A.CIONI; S.ROSSI; G.B.VANNELLI; P.MELIN; M.AKERLUND; M.SERIO |